title: Cost effectiveness of a general practice chronic disease management plan for coronary heart disease in Australia.
abstract: BACKGROUND
  The cost effectiveness of a general practice-based program for managing coronary heart disease (CHD) patients in Australia remains uncertain. We have explored this through an economic model.
  
  
  METHODS
  A secondary prevention program based on initial clinical assessment and 3 monthly review, optimising of pharmacotherapies and lifestyle modification, supported by a disease registry and financial incentives for quality of care and outcomes achieved was assessed in terms of incremental cost effectiveness ratio (ICER), in Australian dollars per disability adjusted life year (DALY) prevented.
  
  
  RESULTS
  Based on 2006 estimates, 263 487 DALYs were attributable to CHD in Australia. The proposed program would add $115 650 000 to the annual national heath expenditure. Using an estimated 15% reduction in death and disability and a 40% estimated program uptake, the program's ICER is $8081 per DALY prevented. With more conservative estimates of effectiveness and uptake, estimates of up to $38 316 per DALY are observed in sensitivity analysis.
  
  
  CONCLUSIONS
  Although innovation in CHD management promises improved future patient outcomes, many therapies and strategies proven to reduce morbidity and mortality are available today. A general practice-based program for the optimal application of current therapies is likely to be cost-effective and provide substantial and sustainable benefits to the Australian community.
authors.affiliation: Flinders Medical Centre, Flinders University, Flinders Drive, Bedford Park, SA 5042, Australia. derek.chew@flinders.edu.au
authors.forename: Derek P
authors.initials: DP
authors.lastname: Chew
authors.forename: Robert
authors.initials: R
authors.lastname: Carter
authors.forename: Bree
authors.initials: B
authors.lastname: Rankin
authors.forename: Andrew
authors.initials: A
authors.lastname: Boyden
authors.forename: Helen
authors.initials: H
authors.lastname: Egan
mesh_terms: D001315:Australia; D002908:Chronic Disease / Q000628:therapy; D003327:Coronary Disease / Q000191:economics* / Q000517:prevention & control / Q000628:therapy; D003362:Cost-Benefit Analysis; D004185:Disability Evaluation; D019468:Disease Management; D005194:Family Practice / Q000191:economics*; D006801:Humans; D016730:Program Development